An interventional study of Walk On! Program in Falls Prevention, sponsored by Wake Forest University Health Sciences. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 126 studies in Mobility Limitation with a site in United States — 31 open to participants now, 35 under way, 3 of them phase 3. Mobility Limitation · United States.
Among the 126 studies in Mobility Limitation with a site in United States, this one is the 19th largest by planned enrollment of the 116 interventional ones that give a count, is one of 10 that started in 2026, is one of 93 with no phase, reaches primary completion later than 13 of the 34 other live ones, and was the 119th registered.
383 studies on the registry are indexed under Mobility Limitation; 106 are open to participants now.
Browse Mobility Limitation studies →31 of the 126 studies in Mobility Limitation with a site in United States are open now. Recruiting first, the newest first:
RxFunction Inc. · Sites in United States
Ages 60+
St. Jude Children's Research Hospital · Sites in United States
Ages 5–20 · Healthy volunteers
The University of Alabama in Huntsville · Sites in United States
Ages 65+ · Healthy volunteers
University of Florida · Sites in United States
Ages 65–90
Northwestern University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Mobility Limitation studies recruiting now, 33 (51%) set no upper age limit and 15 (23%) stop at 75 or younger; 5 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
126 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 11 · Phase 3 9
First in 1997; this study’s year is marked. 10 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 192 is above the median of 46 across 318 interventional studies indexed under Mobility Limitation.
Median enrollment 40 across the 116 interventional studies, 92 across the 10 observational. Of the 83 that completed or were terminated, 30 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 126 have an industry lead sponsor. The 10 most frequent:
Wake Forest University Health Sciences is the lead sponsor of 1,353 studies on the registry; 199 are open to participants now.
Of its 332 completed or terminated interventional studies of FDA-regulated products, 251 (76%) have results posted.
Wake Forest University Health Sciences has 2 studies filed under Mobility Limitation — fewer than ten, so there is no comparison to draw.
13 of the studies in Mobility Limitation with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07125378University of FloridaLiving Independence Through Functional Training | 2026-11-30 |
| NCT05725564Milton S. Hershey Medical CenterTesting Interventions for Mobility Through Exercise (TIME) | 2026-12 |
| NCT06484244Emory UniversityLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease | 2026-12-31 |
| NCT05661084Hebrew SeniorLifeNon-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia | 2026-12-31 |
| NCT07337317The University of Alabama in HuntsvilleEvaluating Stairway Designs for Individuals With Vision Impairment | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 126 studies in Mobility Limitation with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a multi-site, one-arm type-2 hybrid-effectiveness implementation trial. The goal of this clinical trial is to learn if the Walk On! program helps prevent falls in older adults who have trouble moving around or feel socially isolated. Researchers want to know:
Older Adult Participants will:
Despite the clear benefits of walking for individuals at risk of mobility disability, no National Council on Aging (NCOA)-approved evidence-based health programs emphasize walking in a supervised setting, particularly over longer distances. While some programs offer chair exercise, balance, and yoga/tai chi, these do not focus on structured, progressive walking for older adults with limited mobility. Additionally, many older adults living in rural areas have described living in a "health desert" with limited access to evidence-informed health promotion programs.
Walk On! is designed to provide community-based walking for older adults who are physically, socially and/or geographically isolated. This includes a focus on older adults with existing functional limitations and/or mobility challenges that may otherwise limit one's participation in community-based programs and/or individuals who live in rural areas without easy access to safe walking spaces. An underlying goal of this project is to expand access to Walk On! by starting programs in new spaces and places across diverse service sectors.
In brief, Walk On! is a facilitator-led, group-based program consisting of 24 sessions (twice weekly for 60 minutes over a 12 week period) focused on improving walking endurance, strength, and balance for older adults, including those with mobility limitations. Walk On! program facilitators will receive comprehensive implementation support and training to guide their organization in successfully starting and sustaining a program of their own.
Objectives: The long-term goal is to support unique community-based organizations in adopting and sustaining Walk On!. To support this goal this project will evaluate the following objectives:
Objective 1: Evaluate the effectiveness of comprehensive implementation support on community-based organizations adoption and sustainment of Walk On!.
Objective 2: Evaluate the impact of Walk On! on older adults' physical function, falls efficacy, and self-reported loneliness.
Program Older Adult Participants: Inclusion Criteria:
Program Participants: Exclusion Criteria:
Community-Based Organizations (CBOs): Inclusion Criteria:
Community-Based Organizations (CBOs): Exclusion Criteria:
This study uses a single-group model in which all participating Community-Based Organizations (CBOs) receive the same implementation support for Walk On! intervention adoption and delivery. All older adult participants enrolled will receive the intervention. All activities will be unblinded. Intervention participants will be older adults, including those with mobility limitations, recruited from the local community. All intervention activities will take place in person within a community setting. The intervention will focus on improving walking endurance, strength, and balance. The intervention will be delivered by trained facilitators based at CBOs. All facilitators will receive comprehensive training and implementation support as part of this study.
Behavioral: Walk On! Program
24 sessions (twice weekly for 60 minutes over 12 weeks) with a focus on improving walking endurance, strength, and balance in older adults, including those with mobility limitations. All intervention activities will take place in person within a community setting. The intervention will be delivered by trained facilitators based at community-based organizations. All facilitators will receive comprehensive training and implementation support as part of this study.
Adoption of Program
Number of community-based organizations that deliver of one full 12-week round of Walk On! to a minimum of 8 participants who have not previously participated in the program. Data Source: community-based organization's site attendance records.
Time frame: Week 12
Fall Incidence
Number of falls in past 12 weeks (3 months), including number of injurious falls. Data Source(s): Self-report, pre- and post-program assessment surveys. Number of Survey Items: 2. Total Score range: open-ended, 0 to no upper limit (higher score indicates more falls).
Time frame: baseline
Fall Incidence
Number of falls in past 12 weeks (3 months), including number of injurious falls. Data Source(s): Self-report, pre- and post-program assessment surveys. Number of Survey Items: 2. Total Score range: open-ended, 0 to no upper limit (higher score indicates more falls).
Time frame: week 12
Fall self-efficacy
Confidence in performing daily activities without falling; fear of falling Data Source(s): Self-report, pre- and post-program assessments (Confidence in performing daily activities without falling; fear of falling) Number of Survey Items: 11 Total Score range: 11 to 44 (higher score indicates more confidence in performing daily activities without falling; less fear of falling)
Time frame: baseline
Fall self-efficacy
Confidence in performing daily activities without falling; fear of falling. Data Source(s): Self-report, pre- and post-program assessments (Confidence in performing daily activities without falling; fear of falling). Number of Survey Items: 11. Total Score range: 11 to 44 (higher score indicates more confidence in performing daily activities without falling; less fear of falling).
Time frame: week 12
Loneliness
Frequency of feelings of isolation and loneliness (never to always). Data Source(s): Self-report, pre- and post-program assessment surveys. Number of Survey items: 2. Total Score Range: 0 to 8 (higher score indicates higher rating of feelings of loneliness and isolation.
Time frame: baseline, week 12
Mobility
Definition: Distance walked. Data Source(s): 6-Minute Walk Test, pre- and post-program assessments. Total score range: 0 to no upper limit (higher score indicates greater distance walked, greater mobility) .
Time frame: baseline, week 12
Sustainment of Program
Number of community-based organizations that deliver one or more additional full 12-week round(s) of Walk On! to a minimum of 8 participants. Data source is community-based organization's site attendance records.
Time frame: week 36
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for May 2027, 13 months after the start.
Of 201 non-industry interventional studies with no phase under Mobility Limitation, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 42. This study's planned 13 months is below that.
Counting every sponsor, half of 206 studies reached it within 17 months; a quarter within 7 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wake Forest University Health Sciences →